Company NuVasive, Inc.
Equities
NUVA
US6707041058
Medical Equipment, Supplies & Distribution
Business Summary
Number of employees: 3,000
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | - |
Keith Pfeil
DFI | Director of Finance/CFO | 45 | 23-08-31 |
Ryan Donahoe
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Aviva McPherron
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kyle Malone
CTO | Chief Tech/Sci/R&D Officer | - | 10-03-31 |
Investor Relations Contact | - | 21-05-09 | |
Kelly Huller
SEC | Corporate Secretary | 52 | 23-08-31 |
Sean Freeman
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | - |
Keith Pfeil
DFI | Director of Finance/CFO | 45 | 23-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 59,324,167 | 52,305,853 ( 88.17 %) | 6,875,000 ( 11.59 %) | 88.17 % |
Company contact information
![address NuVasive, Inc.(NUVA)](https://cdn.zonebourse.com/static/address/10279.png)
Group companies
Name | Category and Sector |
---|---|
NuVasive Netherlands BV
|
Sector
1st Jan change | Capi. | |
---|---|---|
-5.50% | 181B | |
-5.79% | 99.52B | |
-6.59% | 65.82B | |
-8.38% | 45.21B | |
+8.42% | 43.85B | |
+10.10% | 42.17B | |
+10.97% | 28.75B | |
+18.89% | 25.39B | |
-8.39% | 23.5B |